|
Market Closed -
Deutsche Boerse AG
23:55:02 25/08/2026 +04
|
Pre-market 09:09:16 | |||
| 330.00 EUR | -0.60% |
|
335.00 | +1.52% |
| 08-25 | HHS Plans 2 New FDA Deputy Commissioner Roles Covering Drugs, Technology | MT |
| 08-25 | HHS Plans 2 New FDA Deputy Commissioner Roles Covering Drugs, Technology, CNBC Reports | MT |
| Market Cap | 46.8B 40.1B 37.57B 34.32B 64.77B 4,461B 65.41B 443B 173B 2,251B 176B 172B 7,454B | P/E 2026 * |
54.4x | P/E 2027 * | 24x |
|---|---|---|---|---|---|
| Enterprise Value | 54.3B 46.53B 43.6B 39.83B 75.16B 5,177B 75.9B 514B 200B 2,612B 204B 199B 8,650B | EV / Sales 2026 * |
0.33x | EV / Sales 2027 * | 0.32x |
| Free-Float |
60.3% | Yield 2026 * |
0.94% | Yield 2027 * | 0.97% |
Last Transcript: Humana Inc.
| 1 day | +1.52% | ||
| Current month | +5.10% | ||
| 1 month | -2.94% | ||
| 3 months | +25.00% | ||
| 6 months | +122.67% | ||
| Current year | +51.31% |
| 1 week | 318 |  | 332 |
| 1 month | 304 | | 340 |
| Current year | 142 | | 370 |
| 1 year | 142 | | 370 |
| 3 years | 142 | | 494.1 |
| 5 years | 142 | | 584.8 |
| 10 years | 142 | | 584.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
James Rechtin
CEO | Chief Executive Officer | 55 | 01/07/2024 |
Celeste Brown
DFI | Director of Finance/CFO | 49 | 11/01/2025 |
Bobby Mukundan
CTO | Chief Tech/Sci/R&D Officer | - | 10/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Kurt Hilzinger
CHM | Chairman | 65 | 01/01/2014 |
Frank D'Amelio
BRD | Director/Board Member | 68 | 01/09/2003 |
Karen Katz
BRD | Director/Board Member | 69 | 23/09/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.60% | 0.00% | - | - | 46.8B | |
| -0.54% | +0.68% | +30.09% | -18.92% | 356B | |
| -0.93% | +0.15% | +27.03% | -11.86% | 86.5B | |
| -0.40% | +0.29% | -7.13% | +0.03% | 73.81B | |
| +0.80% | +2.02% | +31.13% | -18.63% | 46.8B | |
| -0.99% | -0.34% | +123.52% | +2.39% | 32.11B | |
| +0.57% | -1.95% | +13.96% | -37.41% | 10.4B | |
| +1.19% | +2.72% | -12.77% | +130.73% | 2.82B | |
| +0.49% | -2.36% | +56.14% | +227.78% | 2.19B | |
| +1.45% | +0.43% | +11.58% | -30.93% | 1.98B | |
| Average | +0.44% | +0.37% | +30.39% | +27.02% | 68.07B | |
| Weighted average by Cap. | +0.34% | +0.81% | +29.71% | -13.28% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 163B 139B 131B 119B 225B 15,514B 227B 1,541B 600B 7,827B 611B 598B 25,922B | 169B 145B 135B 124B 234B 16,086B 236B 1,598B 622B 8,116B 634B 620B 26,876B |
| Net income | 886M 759M 711M 650M 1.23B 84.46B 1.24B 8.39B 3.27B 42.61B 3.33B 3.25B 141B | 2.02B 1.73B 1.62B 1.48B 2.79B 192B 2.82B 19.1B 7.44B 97.01B 7.57B 7.41B 321B |
| Net Debt | 7.51B 6.43B 6.03B 5.51B 10.39B 716B 10.49B 71.09B 27.68B 361B 28.19B 27.57B 1,196B | 6.41B 5.49B 5.15B 4.7B 8.87B 611B 8.96B 60.71B 23.63B 308B 24.07B 23.54B 1,021B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25/08/26 | €330.00 | -0.60% | 0 |
| 24/08/26 | €332.00 | +2.47% | 0 |
| 21/08/26 | €324.00 | 0.00% | 0 |
| 20/08/26 | €324.00 | +1.25% | 0 |
| 19/08/26 | €320.00 | -3.03% | 0 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HUM Stock
- HUM Stock
Select your edition
All financial news and data tailored to specific country editions
